VUR Review
Treating VUR
About Deflux
Deflux Learning Center

Pediatric Urologists in District Of Columbia

Select a State District Of Columbia (DC)

Cities

Washington

VUR Review
Treating VUR
About Deflux
Deflux Learning Center

Important Safety Information
Privacy Policy
Terms of Use
Contact

HCP Reference US

Reference:

Galderma. Available at: https://www.galderma.com/uk/restylane. Accessed May 13, 2020.

HCP US Footer

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

Deflux^® (hyaluronic acid/dextranomer) is contraindicated in patients with any of the following conditions: non-functional kidney(s), hutch diverticulum, ureterocele, active voiding dysfunction, and ongoing urinary tract infection.

Safety and efficacy of treatment of duplex systems, use of more than 6 mL of Deflux (3 mL at each ureteral orifice) at the same treatment session, and treatment of children under 1 year of age have not been established.

APM039B

© Palette Life Sciences. Deflux^® and NASHA^® are registered trademarks. All rights reserved.

X